ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2841

Infection Is the Major Trigger of Adult Hemophagocytic Syndrome, an Orphan Systemic Hyperinflammatory, Life-Threatening Disease: Analysis in 147 Patients (GEAS-SEMI Registry)

Pilar Brito-Zerón1, Alejandra Flores-Chavez2,3,4, Pedro Moral Moral5, A. Martínez-Zapico6, Pilar Hernández-Jimenez7, Guadalupe Fraile Rodriguez8, Patricia Perez Guerrero9, Eva Fonseca10, Angel Robles11, María Vaquero Herrero12, Angela Ruiz de Temiño de la Peña13, Maria José Forner14, José Ramón Larrañaga15, Mónica Rodriguez Carballeira16, Luis Fernando Viejo Llorente17, Manuel Ruiz Muñoz18, Roberto Hurtado19, César Morcillo20, Soledad Retamozo21 and Manuel Ramos-Casals22,23, 1Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, 2Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Spain., Barcelona, Spain, 3Programa de Doctorado en Ciencias Médicas, Centro Universitario de Investigaciones Biomédicas (CUIB), Universidad de Colima, Colima, Mexico, Mexico, Mexico, 4Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, 5Hospital La Fé Valencia, Valencia, Spain, 6Hospital Universitario de Asturias, Oviedo, Oviedo, Spain, 7Internal Medicine, Hospital 12 de Octubre, Madrid, Spain, 8Internal Medicine, Hospital Ramón y Cajal, Madrid, Madrid, Spain, 9Department of Internal Medicine, Hospital Universitario Puerta del Mar, Cádiz, Cadiz, Spain, 10Internal Medicine, Hospital de Cabueñes, Gijón, Gijón, Spain, 11Internal Medicine, Hospital La Paz, Madrid, Madrid, Spain, 12Complejo Asistencial Universitario de Salamanca, Salamanca, Spain, 13Hospital Rio Hortega Valladolid, Valladolid, Spain, 14Department of Internal Medicine, Hospital Clínico de Valencia, Valencia, Spain, 15Department of Internal Medicine, Hospital Xeral, Vigo, Vigo, Spain, 16Hospital Mutua de Terrasa, Terrasa, Spain, 17Hospital Virgen de la Salud Toledo, Toledo, Spain, 18Department of Internal Medicine, Hospital Universitario Fundacion Alcorcón, Madrid, Spain, 19Hospital Vega Baja de Orihuela, Alicante, Spain, 20Department of Medicine, Hospital CIMA-Sanitas, Barcelona, Barcelona, Spain, 21Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, 22Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 23Department of Medicine, University of Barcelona, Barcelona, Spain., Barcelona, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Infection, inflammation and registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Infection-related Rheumatic Disease

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Hemophagocytic syndrome or hemophagocytic lymphohistiocytosis (HLH) is an increasingly-recognized condition in adults, characterized by a wide range of etiologies, symptoms and outcomes, but with a common etiopathogenic pathway leading to organ damage: an excessive hyperinflammatory response. We analyzed the role of infections as triggers of adult hemophagocytic syndrome in a National Cohort Registry.

Methods: In June 2013, the Study Group on Autoimmune Diseases (GEAS) of the Spanish Society of Internal Medicine created the national registry of patients with HLH. Patients fulfilled the diagnostic guidelines for HLH proposed by the Histiocyte Society in 1991 and updated in 2004. We investigated infections (viruses, bacteria, parasites and fungi) as causative external factors potentially involved in initiate the disease.

Results: On June 15, 2017, a total of 147 patients with HLH were included in the GEAS-SEMI Registry, 87 (59%) men and 60 (41%) women, with a mean age at diagnosis of HLH of 44; 18% were not born in Spain. The main signs and symptoms at presentation consisted of fever in 132 (90%) patients, splenomegaly in 80 (54%), polyadenopathies in 71 (48%) and hepatomegaly in 22 (15%) patients. The main internal organ involvements included pulmonary in 49 (33%) patients, renal in 46 (31%), gastrointestinal in 41 (28%) and CNS in 32 (22%) patients. The main analytical markers consisted of ferritin > 500 ng/mL in 143 (97%, mean 15498 ng/mL), thrombocytopenia <100,000/mm3 in 123 (84%), anemia < 9 g/dL in 106 (72%), and neutropenia <1000/mm3 in 65 (44%). Tissular hemophagocytosis was confirmed in 133/143 (93%) patients. Death occurred in 79 (54%) patients; a higher mortality rate was found in patients with an underlying neoplasia (33% vs 16% in survivals, p=0,023) and in those with severe anemia (85% vs 60%, p=0.001) and thrombocytopenia (95% vs 72%, p<0.001). Mean age at diagnosis was higher in patients who died in comparison with survivors (56.8 vs 42.1 yrs, p<0.001). An infectious trigger was detected in 88 (60%) of patients, mainly viruses in 37 (25%, Epstein-Barr virus infection in 16 cases), bacteria in 23 (16%, mycobacterium infection in 9 cases), fungi in 14 (10%, candida in 5 cases) and parasites in 9 (6%, leishmaniasis in 8 cases).

Conclusion:

The rate of mortality of adult patients diagnosed with hemophagocytic syndrome exceeds 50% of cases, especially in patients with underlying hematological diseases and in those with advanced age. An infection as trigger of the hyperinflammatory response was demonstrated in 60% of cases, with EBV, mycobacterium and leishmanial being the microorganisms more frequently isolated. Active infections in a patient with suspected HLH should always be treated appropriately.


Disclosure: P. Brito-Zerón, None; A. Flores-Chavez, None; P. Moral Moral, None; A. Martínez-Zapico, None; P. Hernández-Jimenez, None; G. Fraile Rodriguez, None; P. Perez Guerrero, None; E. Fonseca, None; A. Robles, None; M. Vaquero Herrero, None; A. Ruiz de Temiño de la Peña, None; M. J. Forner, None; J. R. Larrañaga, None; M. Rodriguez Carballeira, None; L. Fernando Viejo Llorente, None; M. Ruiz Muñoz, None; R. Hurtado, None; C. Morcillo, None; S. Retamozo, None; M. Ramos-Casals, None.

To cite this abstract in AMA style:

Brito-Zerón P, Flores-Chavez A, Moral Moral P, Martínez-Zapico A, Hernández-Jimenez P, Fraile Rodriguez G, Perez Guerrero P, Fonseca E, Robles A, Vaquero Herrero M, Ruiz de Temiño de la Peña A, Forner MJ, Larrañaga JR, Rodriguez Carballeira M, Fernando Viejo Llorente L, Ruiz Muñoz M, Hurtado R, Morcillo C, Retamozo S, Ramos-Casals M. Infection Is the Major Trigger of Adult Hemophagocytic Syndrome, an Orphan Systemic Hyperinflammatory, Life-Threatening Disease: Analysis in 147 Patients (GEAS-SEMI Registry) [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/infection-is-the-major-trigger-of-adult-hemophagocytic-syndrome-an-orphan-systemic-hyperinflammatory-life-threatening-disease-analysis-in-147-patients-geas-semi-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/infection-is-the-major-trigger-of-adult-hemophagocytic-syndrome-an-orphan-systemic-hyperinflammatory-life-threatening-disease-analysis-in-147-patients-geas-semi-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology